Status:
COMPLETED
HAL-RAR Technique for Treating Hemorrhoids
Lead Sponsor:
Amalia Fleming General Hospital
Collaborating Sponsors:
Sismanoglio - Amalia Fleming General Hospital
Conditions:
Hemorrhoidal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A wide variety of methods has been proposed for treating hemorrhoidal disease with excisional hemorrhoidectomy remaining the gold standard. The aim of this trial is to assess the safety and effectiven...
Detailed Description
This is a retrospective, single-institution, study conducted from January 2010 to November 2019. Grade of hemorrhoidal disease was assessed according to Goligher's classification. Patients with grade ...
Eligibility Criteria
Inclusion
- Patients with
- grade II hemorrhoidal disease, resistant to conservative treatment
- grade III hemorrhoidal disease,
- grade IV hemorhoidal disease,
- that underwent the HAL-RAR technique.
Exclusion
- pregnancy
- coagulation disorders
- patients with major comorbidities (American Society of Anesthesiologists \[ASA\] ≥3),
- psychiatric conditions preventing collaboration and follow-up
- other concomitant anorectal disease (rectal prolapse, anal fissure, anal stenosis, perianal fistula or abscess, fecal incontinence)
- previous pelvic radiotherapy
- declined consent
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04778124
Start Date
January 1 2010
End Date
November 1 2019
Last Update
March 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.